Patents & Trademarks

Use of Patents

Savanna Health manufactures its products under a license for the use of patents owned by a sister company, Seroctin Research & Technologies, Inc. These products include the branded products Sleep Aid by Savanna and Sleep Aid AquaMist. Sleep Aid AquaMist is also sold in bulk to other companies for licensed use under their own brand identities. Other brand names used by Seroctin Research and Savanna Health include Seroctin® and SeroCalm™.

List of U.S. Patents

No. 6,667,308 — Issued December 23, 2003

ABSTRACT: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen–containing group, a nitrogen– or another oxygen containing group, and a C.sub.1 –C.sub.4 alkoxy group, obtainable from monocotyledonous plants, animals that eat such plants, or chemical synthesis, have been found to act as an antidepressant or otherwise a treatment for bettering mood, a therapy for improving sexual desire or performance, an adjunctive therapy for achieving weight loss, and an adjunctive therapy for substance abuse and addiction. These compounds, at concentrations suitable for human therapeutic use, may be obtained from plants such as corn in their early growth stages and from parts of animals such as the velvet antler tips of deer and elk.

No. 7,507,731 — Issued March 24, 2009

ABSTRACT: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen–containing group, a nitrogen or another oxygen containing group, and a C.sub.1–C.sub.4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids–cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

No. 7,521,467 — April 21, 2009

ABSTRACT: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen–containing group, a nitrogen or another oxygen containing group, and a C.sub.1–C.sub.4 alkoxy group, obtainable from monocotyledonous plants, or by chemicals synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids–cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield. (See Claims in the patents for distinctions between this patent and Patents No. 7.521,468 and 7,524,877.)

No. 7,521,468 — Issued April 21, 2009

ABSTRACT: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen–containing group, a nitrogen or another oxygen containing group, and a C.sub.1–C.sub.4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids–cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield. (See Claims in the patents for distinctions between this patent and Patents No. 7.521,467 and 7,524,877.)

No. 7,524,877 — Issued April 28, 2009

ABSTRACT: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen–containing group, a nitrogen or another oxygen containing group, and a C.sub.1–C.sub.4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids–cyclic hydroxyamic acids, lactams, and corresponding gluxosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield. (See Claims in the patents for distinctions between this patent and Patents No. 7.521,467 and 7,521,468.)

No. 7,541,356 — Issued June 2, 2009

ABSTRACT: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen–containing group, a nitrogen or another oxygen containing group, and a C.sub.1–C.sub.4 alkoxy group, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to act as weight loss agents, appetite suppressants, mood enhancers and adjunctive therapy for arthritis, sleep apnea, fibromyalgia, diabetes and hyperglycemia. Additional chemical compounds of the present invention may include benzoxazinoids–cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

No. 7,794,761 — Issued September 14, 2010

ABSTRACT: Phenolic compounds with a phenolic molecule to which are covalently linked an oxygen–containing group, a nitrogen or another oxygen containing group, and a C.sub.1–C.sub.4 alkoxy group, or their precursor compounds, obtainable from monocotyledonous plants, or by chemical synthesis, have been found to calm and/or reduce anxiety and related behaviors and states in humans and animals. Additional chemical compounds of the present invention may include benzoxazinoids–cyclic hydroxyamic acids, lactams, and corresponding glucosides, which may serve as precursors to phenolic compounds. The phenolic compounds and precursors of phenolic compounds of the present invention, at concentrations suitable for human and animal therapeutic use, may be obtained from monocotyledonous plants such as corn in their early growth states which are timely harvested for optimum yield.

Registered Trademarks

Trademark Reg. No. Date Issued Held By
Seroctin 3193670 January 2, 2007 SRT
Savanna 4351414 June 11, 2013 SRT
Savanna Health 4502645 March 25, 2014 SRT
Designed by Nature, Validated by Science 4506642 April 1, 2014 SRT

Copies of patents and trademark grants are available.